Nearly half of people diagnosed with advanced cancer over a recent 5-year period did not undergo next-generation sequencing, according to results of a retrospective cohort study.Rates improved over ...
When comprehensive tissue next-generation sequencing (NGS) fails, liquid biopsy should be the reflex strategy, especially in ...
Kelly, MD, MBA, and participants discussed key considerations for biomarker testing in upper GI cancers. Biomarker status has ...
NeoGenomics Inc. used its latest earnings call to underscore a solid growth story, with management striking a confident but measured tone. Double‑digit revenue gains, accelerating next‑generation ...
Q1 2026 Earnings Call April 28, 2026 4:30 PM EDTCompany ParticipantsPriya Vedaraman - Senior Vice President of FinanceAnthony Zook ...
New innovations improve microbial identification, outbreak tracking, and NGS workflows, enhancing diagnostic speed, accuracy, ...
DNA/RNA-based next-generation sequencing allows earlier diagnosis of neoplastic bile duct strictures, a prospective multicenter real-time study finds.
The NGS kits market presents significant opportunities driven by advancements in genomic sequencing, especially in DNA and RNA preparation kits. Innovation is fueled by reduced sequencing costs and ...
NGS utilization increased over time but left substantial proportions untested across metastatic breast, prostate, pancreatic, ...
Initially treated for tuberculosis, a young patient’s life took a dramatic turn when advanced diagnostics uncovered a rare ...
ACT Genomics today announced a significant upgrade to the ACTDrug® series, its next-generation sequencing (NGS) genomic ...
Viral safety will be a major challenge for the CGT industry for the foreseeable future, according to new analysis.